Shanghai Pharmaceuticals Holding Co Class H (($SHPMF)) announced an update on their ongoing clinical study. Shanghai Pharmaceuticals Holding Co.

For young patients with primary multimetastatic Ewing sarcoma, pazopanib is well-tolerated and effective, according to a ...

Inhibrx Biosciences, Inc. reports strong phase 2 results for ozekibart in chondrosarcoma, with new cancer data and key ...

Survival rates from small trial suggest that adding pazopanib to standard treatment for Ewing sarcoma in children may extend lives without adding severe toxicity.

A groundbreaking study led by researchers at Children’s Hospital Los Angeles offers critical insights into Ewing Sarcoma, a rare and aggressive bone and soft tissue cancer that primarily affects ...

Ewing sarcoma is a rare and serious diagnosis, largely impacting children. The disease only accounts for about 1% of all pediatric cancers in the U.S., with about 250 children diagnosed every year, ...

Immune Checkpoint Inhibitors in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor–Resistant Chemotherapy-Naïve Advanced Non–Small Cell Lung Cancer: A Meta-Analysis Based on Eight Randomized ...

Secreted gonadotropin-releasing hormone (GnRH) acts on the anterior pituitary gland to initiate puberty. Mutations in the protein immunoglobulin superfamily member 10 (IGSF10) have been linked to ...

Ewing sarcoma is a rare, aggressive cancer that primarily strikes children and adolescents, yet it can present in infants, where it is exceptionally uncommon. U.S. registry data show an incidence of ...

A 14-year-old has beaten a rare cancer that doctors initially misdiagnosed as a sports injury. A video released by Cleveland Clinic Children's Hospital shows Evan Lallo ringing the "bravery bell" back ...

"'Just keep going' is my message to others," Evan Lallo said. A 14-year-old has beaten a rare cancer that doctors initially misdiagnosed as a sports injury. A video released by Cleveland Clinic ...